STAAR Surgical Co
Cash Flow Statement
| Line Item | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-80.4M | $-20.2M | $21.3M | $39.7M | $27.5M | $14.0M | $5.0M | $-2.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $8.3M | $6.9M | $5.1M | $4.5M | $3.6M | $3.7M | $2.4M | $3.1M |
| Amortization | — | — | $13.0K | $28.0K | $34.0K | $34.0K | $34.0K | $221.0K |
| Stock-Based Compensation | $30.6M | $27.2M | $23.5M | $20.4M | $14.6M | $10.5M | $6.8M | $3.2M |
| Net Cash from Operating Activities | $-34.2M | $15.7M | $14.6M | $35.7M | $44.0M | $25.8M | $12.8M | $2.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $5.8M | $23.4M | $18.2M | $18.1M | $13.6M | $10.1M | $2.2M | $1.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $46.3M | $-59.2M | $74.3M | $-156.4M | $-13.6M | $-10.2M | $-2.2M | $-1.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $6.5M | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-4.6M | $5.7M | $7.4M | $8.3M | $17.8M | $149.0K | $74.6M | $2.4M |
| Net Change in Cash | $9.0M | $-38.9M | $96.6M | $-113.2M | $47.3M | $16.0M | $85.4M | $4.5M |
| Free Cash Flow | $-40.1M | $-7.7M | $-3.6M | $17.6M | $30.3M | $15.7M | $10.5M | $1.8M |